On June 12, 2025, the chairman of Shanghai Golden Ripples International Trade Co., Ltd. and Russian partners jointly visited Dongguan Group. The two sides had in-depth discussions on the cooperation model and reached important consensus. Both sides will jointly promote the development of the enterprise through a cooperative approach of channel intercommunication and resource sharing.
Representatives from Russia’s leading frozen chicken paw producer—Factory No. 77—visited Shanghai Golden Ripples for in-depth discussions on collaboration models. The two parties reached a significant agreement to jointly develop the Chinese market for pre-packaged frozen chicken paws, catering to the growing demand for high-quality imported ingredients. With advanced production technology and stringent quality control, Factory No. 77 holds strong potential in China. Shanghai Golden Ripples will leverage its established sales network to promote branded Russian frozen chicken paws in China. This partnership marks a further step in Sino-Russian food trade cooperation.
Shanghai Golden Ripples has recently announced its entry into the beer export business, marking a significant step in the company’s diversified development strategy. To advance this new venture, the company held meetings with multiple potential clients and suppliers, focusing on key issues such as beer selection, cooperation models, and market strategies. The meetings aimed to ensure product quality and supply chain stability while exploring innovative collaboration methods to meet the diverse needs of the global market. Shanghai Golden Ripples stated that it will leverage its extensive international trade experience to provide high-quality beer products to consumers worldwide.
Recently, Shanghai Golden Ripples and its partners visited China United Engineering Co., Ltd. to discuss ongoing collaborative projects, such as production line initiatives, and explore future cooperation opportunities. Zhang Tongyi, Deputy General Manager of China United Engineering Co., Ltd., attended the meeting. The discussions focused on strengthening existing partnerships and identifying new areas for collaboration to promote mutual growth in engineering and technology sectors.
Recently, Shanghai Cell Therapy Group revisited Shanghai Golden Ripples International Trade Co., Ltd. to further discuss future collaboration. The meeting aimed to strengthen the partnership between the two companies in the field of cell therapy and jointly promote the development of the biomedical industry.
As a leading domestic enterprise in cell therapy technology research and development, Shanghai Cell Therapy Group has been committed to the innovation and application of advanced technologies. Meanwhile, Shanghai Golden Ripples boasts extensive experience in international trade and supply chain management. The collaboration will leverage the strengths of both parties to explore more market opportunities and enhance international competitiveness.
This revisit not only solidified the partnership but also laid a solid foundation for future strategic cooperation. Both sides expressed their commitment to maintaining close communication and jointly advancing the implementation of collaborative projects.
Shanghai Golden Ripples visited Shanghai Cell Therapy Group today, gaining insights into its latest achievements and technological advances in cell therapy. As a leading enterprise in China’s cell therapy sector, the group is actively promoting industrial innovation and development.